fullerene c60 has been researched along with Brain Swelling in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darabi, S; Mohammadi, MT | 1 |
| Aryafar, M; Mohammadi, MT; Sarami Foroshani, M; Sobhani, ZS | 1 |
2 other study(ies) available for fullerene c60 and Brain Swelling
| Article | Year |
|---|---|
Fullerenol nanoparticles decrease ischaemia-induced brain injury and oedema through inhibition of oxidative damage and aquaporin-1 expression in ischaemic stroke.
Topics: Animals; Aquaporin 1; Brain Edema; Brain Infarction; Brain Injuries; Cerebrovascular Circulation; Disease Models, Animal; Fullerenes; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Nanoparticles; Neurologic Examination; Nitrates; Oxidative Stress; Rats; Rats, Wistar; Statistics, Nonparametric | 2017 |
Fullerenol Nanoparticles Decrease Blood-Brain Barrier Interruption and Brain Edema during Cerebral Ischemia-Reperfusion Injury Probably by Reduction of Interleukin-6 and Matrix Metalloproteinase-9 Transcription.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Capillary Permeability; Disease Models, Animal; Down-Regulation; Fullerenes; Infarction, Middle Cerebral Artery; Interleukin-6; Male; Matrix Metalloproteinase 9; Nanoparticles; Neuroprotective Agents; Rats, Wistar; Reperfusion Injury; Transcription, Genetic | 2018 |